Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Prevalence and determinants of potentially inappropriate medication use in Hong Kong older patients: a cross-sectional study.

Tytuł:
Prevalence and determinants of potentially inappropriate medication use in Hong Kong older patients: a cross-sectional study.
Autorzy:
Zhang H; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Sha Tin, New Territories, Hong Kong.
Wong EL; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Sha Tin, New Territories, Hong Kong .
Wong SY; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Sha Tin, New Territories, Hong Kong.
Chau PY; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Sha Tin, New Territories, Hong Kong.
Yip BH; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Sha Tin, New Territories, Hong Kong.
Chung RY; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Sha Tin, New Territories, Hong Kong.
Lee EK; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Sha Tin, New Territories, Hong Kong.
Lai FT; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Sha Tin, New Territories, Hong Kong.
Yeoh EK; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Sha Tin, New Territories, Hong Kong.
Źródło:
BMJ open [BMJ Open] 2021 Jul 22; Vol. 11 (7), pp. e051527. Date of Electronic Publication: 2021 Jul 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: [London] : BMJ Publishing Group Ltd, 2011-
MeSH Terms:
Inappropriate Prescribing*
Potentially Inappropriate Medication List*
Aged ; Cross-Sectional Studies ; Female ; Hong Kong/epidemiology ; Humans ; Male ; Prevalence
References:
J Am Med Dir Assoc. 2015 Jun 1;16(6):535.e1-12. (PMID: 25869992)
BMC Public Health. 2010 Jul 06;10:397. (PMID: 20602806)
J Am Geriatr Soc. 2015 Nov;63(11):2227-46. (PMID: 26446832)
J Am Geriatr Soc. 2016 Apr;64(4):788-97. (PMID: 27100575)
Arch Intern Med. 1991 Sep;151(9):1825-32. (PMID: 1888249)
J Am Geriatr Soc. 2012 Apr;60(4):616-31. (PMID: 22376048)
J Am Geriatr Soc. 2019 Apr;67(4):674-694. (PMID: 30693946)
Scand J Prim Health Care. 2009;27(3):153-9. (PMID: 19462339)
J Am Med Dir Assoc. 2016 Sep 1;17(9):862.e1-9. (PMID: 27473899)
Health Policy Plan. 2013 Oct;28(7):717-29. (PMID: 23161587)
Soc Sci Med. 1995 Jun;40(12):1707-15. (PMID: 7660184)
Arch Intern Med. 1997 Jul 28;157(14):1531-6. (PMID: 9236554)
PLoS One. 2014 Aug 19;9(8):e105425. (PMID: 25136981)
Curr Aging Sci. 2019;12(2):121-154. (PMID: 31096900)
Lancet. 2007 Jul 14;370(9582):173-184. (PMID: 17630041)
BMC Geriatr. 2011 Nov 30;11:79. (PMID: 22129458)
Pharmacoepidemiol Drug Saf. 2012 Dec;21(12):1269-79. (PMID: 22517563)
Dtsch Arztebl Int. 2010 Aug;107(31-32):543-51. (PMID: 20827352)
Br J Clin Pharmacol. 2011 Sep;72(3):482-9. (PMID: 21557760)
Eur J Clin Pharmacol. 2007 Aug;63(8):725-31. (PMID: 17554532)
Age Ageing. 2015 Mar;44(2):213-8. (PMID: 25324330)
Nurs Clin North Am. 2017 Sep;52(3):457-468. (PMID: 28779826)
PLoS One. 2012;7(8):e43617. (PMID: 22928004)
J Am Geriatr Soc. 2010 Jan;58(1):203-5. (PMID: 20122071)
BMC Geriatr. 2021 Feb 2;21(1):98. (PMID: 33530943)
Ann Pharmacother. 2014 Nov;48(11):1425-33. (PMID: 25159001)
Arch Gerontol Geriatr. 2008 Jul-Aug;47(1):35-51. (PMID: 17675177)
J Am Geriatr Soc. 2011 Aug;59(8):1521-30. (PMID: 21797829)
Arch Intern Med. 2003 Dec 8-22;163(22):2716-24. (PMID: 14662625)
Eur J Clin Pharmacol. 2018 Jun;74(6):679-700. (PMID: 29589066)
J Am Geriatr Soc. 2015 Jul;63(7):1471-2. (PMID: 26189852)
Eur J Gen Pract. 2017 Dec;23(1):69-77. (PMID: 28271916)
PLoS One. 2016 Nov 30;11(11):e0166359. (PMID: 27902720)
Contributed Indexing:
Keywords: GERIATRIC MEDICINE; Health & safety; PUBLIC HEALTH
Entry Date(s):
Date Created: 20210724 Date Completed: 20210804 Latest Revision: 20220119
Update Code:
20240105
PubMed Central ID:
PMC8728374
DOI:
10.1136/bmjopen-2021-051527
PMID:
34301670
Czasopismo naukowe
Objectives: To assess the prevalence of potentially inappropriate medication (PIM) use in Hong Kong older patients visiting general outpatient clinics (GOPCs) between 2006 and 2014 and to identify factors associated with PIM use among older adults visiting GOPCs in 2014.
Design: Cross-sectional study.
Setting: GOPC.
Participants: Two study samples were constructed including a total of 844 910 patients aged 65 and above from 2006 to 2014 and a cohort of 489 301 older patients in 2014.
Measurements: Two subsets of the 2015 American Geriatrics Society Beers criteria-PIMs independent of diagnosis and PIMs due to drug-disease interactions-were used to estimate the prevalence of PIM use over 12 months. PIMs that were not included in the Hospital Authority drug formulary or with any specific restriction or exception in terms of indication, dose or therapy duration were excluded. Characteristics of PIM users and non-PIM users visiting GOPCs in 2014 were compared. Independent associations between patient variables and PIM use were assessed by stepwise multivariable logistic regression analysis.
Results: The 12-month period prevalence of PIM use decreased from 55.56% (95% CI 55.39% to 55.72%) in 2006 to 47.51% (95% CI 47.37% to 47.65%) in 2014. In the multivariable regression analysis, the strongest factor associated with PIM use was the number of different drugs prescribed (adjusted OR, AOR 23.01, 95% CI 22.36 to 23.67). Being female (AOR 0.89, 95% CI 0.85 to 0.87 for males vs females) and having a greater number of GOPC visits (AOR 1.83, 95% CI 1.78 to 1.88) as well as more than six diagnoses (AOR 1.43, 95% CI 1.36 to 1.52) were associated with PIM use.
Conclusions: The overall prevalence of PIM use in older adults visiting GOPCs decreased from 2006 to 2014 in Hong Kong although the prevalence of PIM use was still high in 2014. Patients with female gender, a larger number of medications prescribed, more frequent visits to GOPCs, and more than six diagnoses were at higher risk for PIM use.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies